Comparing Ezetimibe vs Praluent
| Ezetimibe | Praluent (alirocumab) |
|
|---|
| Ezetimibe | Praluent (alirocumab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Ezetimibe is effective at lowering cholesterol levels when taken on a regular basis and can be combined with certain other cholesterol treatments in some patients to further reduce blood lipids... View more |
Prescription only
Praluent is a PCSK9 inhibitor that may be used to reduce LDL-C levels in people with primary hyperlipidemia, genetically high cholesterol, or to reduce the risk of a heart attack, stroke, or... View more |
Related suggestions High Cholesterol
High Cholesterol, Familial Heterozygous
Popular comparisons
|
|||||||||||||||
| More about Ezetimibe | More about Praluent (alirocumab) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Ezetimibe has an average rating of 4.0 out of 10 from a total of 174 ratings on Drugs.com. 25% of reviewers reported a positive effect, while 59% reported a negative effect. |
Praluent has an average rating of 6.3 out of 10 from a total of 306 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 31% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Ezetimibe side effects |
View all Praluent side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Ezetimibe prices |
View all Praluent prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Zetia |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
22 hours |
480 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 67 drugs are known to interact with Ezetimibe:
|
A total of 2 drugs are known to interact with Praluent:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||
| First Approval Date | |||||||||||||||||
|
October 25, 2002 |
July 24, 2015 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.